Medtronic Inc 7000 Central Avenue Neminneapolis Mn 55432 3576 Pma Numberp960009 Supplement Numbers422 Date Received02 24 2022 Decision Date03 25 2022 Product Code Mhy Advisory Committee Neurology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Medtronic Inc 7000 Central Avenue Neminneapolis Mn 55432 3576 Pma Numberp960009 Supplement Numbers422 Date Received02 24 2022 Decision Date03 25 2022 Product Code Mhy Advisory Committee Neurology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P960009S422 MEDTRONIC Inc.7000 Central Avenue Neminneapolis, MN 55432-3576 PMA NumberP960009 Supplement NumberS422 Date Received02/24/2022 Decision Date03/25/2022 Product Code MHY  Advisory Committee Neurology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	Activa® Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™	2022-03-25